Magic Mushrooms Can Rewire a Stressed Brain. Scientists Found a Way to Separate That from the Trip

Scientists have found the exact biological switch to design safer, non-hallucinogenic medicines using psilocybin.

by · ZME Science

Can you heal a stressed brain using magic mushrooms, but without the trip? Researchers are increasingly starting to believe so.

In a new study, researchers discovered that psilocybin, the psychoactive compound in magic mushrooms, can reshape neural connections through a cellular mechanism that is distinct from the one responsible for a behaviour associated with psychedelic effects. However, this has only been proven in mice so far.

A close-up shot of mushrooms against a bright red background. Image credits: Marek Piwnicki/Pexels

The researchers also found something unexpected. Psilocybin doesn’t rewire every brain in the same way. In mice exposed to chronic stress, the drug encouraged the formation of new neural connections while helping preserve existing ones. In mice that hadn’t experienced chronic stress, it promoted a different pattern of remodeling.

The finding could help scientists develop treatments that preserve the brain’s ability to rebuild connections without requiring patients to undergo an intense altered state of consciousness.

“I consider this work a major advance, particularly in our understanding of how psilocybin reshapes neural circuits and its potential implications for treating mental disorders,” said Yi Zuo, one of the study authors, and a professor of developmental biology at UC Santa Cruz (UCSC).

How does psilocybin rebuild brain connections?

To investigate how psilocybin changes the brain, the researchers used two-photon microscopy, an advanced imaging technique that allowed them to follow individual neural structures in living mice over several weeks.

They focused on dendritic spines, tiny protrusions on neurons that receive signals from neighboring nerve cells. These structures help form synapses, the junctions through which neurons communicate and support functions such as learning, memory, and emotional regulation.

Within 24 hours of psilocybin administration, the researchers observed a substantial increase in newly formed dendritic spines. The drug also accelerated their maturation. 

Normally, new spines begin as small, immature structures, many of which disappear before developing into stable connections. However, after receiving psilocybin a much larger proportion developed into mushroom-shaped structures associated with greater stability and stronger communication between neurons.

×

Get smarter every day...

Stay ahead with ZME Science and subscribe.

Daily Newsletter
The science you need to know, every weekday.

Weekly Newsletter
A week in science, all in one place. Sends every Sunday.
No spam, ever. Unsubscribe anytime. Review our Privacy Policy.

Thank you! One more thing...

Please check your inbox and confirm your subscription.

RelatedPosts

How the brain loses and gains consciousness
Between Life and Death: What Near-Death Experiences Reveal About Consciousness
The secret to a long life: consciousness
Magic mushrooms have been consumed for centuries. Here’s why

“These newly formed connections can integrate into existing neural circuitry and persist over time, leaving a lasting structural trace of psilocybin’s effects on the brain,” Jacob Baker, first author of the study and a PhD student at UCSC, said.

But psilocybin wasn’t simply making the brain grow more connections. It was also helping reorganize the ones already there.

Neural remodeling and chronic stress

In mice that hadn’t been exposed to chronic stress, the initial burst of new spine formation gradually subsided over the following three weeks. Meanwhile, some connections that had existed before treatment were eliminated.

This suggests that psilocybin promotes a process of neural remodeling, in which new connections form while others are pruned away. More connections, in other words, aren’t necessarily the whole story.

The results were particularly intriguing when researchers examined mice subjected to chronic, unpredictable mild stress. Prolonged stress can disrupt neural circuitry and contribute to the loss of synaptic connections. But in these mice, psilocybin produced an especially strong increase in new spine formation while reducing the excessive loss of existing connections.

“These findings challenge the prevailing view that psilocybin simply increases neural connectivity and suggest that its effects depend on the brain’s underlying condition,” Zuo said.

The findings raise the possibility that psilocybin could help restore neural circuits disrupted by stress, although the study did not establish that these structural changes translate into improvements in depression or other psychiatric conditions.

Separating brain rewiring from psychedelic effects

The next question was perhaps the most intriguing. Could scientists isolate these changes in neural connections from the effects that make psilocybin a psychedelic in the first place?

To do this, they investigated serotonin 2A receptors (5-HT2ARs), proteins on cell surfaces that respond to chemical signals and play a central role in the effects of classic psychedelics.

They focused on Layer 5 pyramidal neurons, a population of cells in the cerebral cortex that sends information to other brain regions and contains high levels of these receptors.

Using genetically modified mice, the team selectively manipulated serotonin 2A receptors in these neurons to determine whether they were responsible for psilocybin’s structural effects or its psychedelic-associated behavior.

First, the researchers restored the receptors exclusively in Layer 5 pyramidal neurons. Psilocybin could still stimulate new synapse formation and maturation, but the mice did not display the characteristic head-twitch response, a repetitive movement commonly used as a rodent proxy for psychedelic activity.

The researchers then performed the opposite experiment, removing serotonin 2A receptors specifically from these neurons. This time, psilocybin could no longer produce the same structural changes in neural connections. Yet the mice continued to exhibit the head-twitch response.

The contrast was striking. The receptors in these particular neurons were necessary for psilocybin to remodel neural connections, but they weren’t necessary for the head-twitch response. Conversely, restoring the receptors only in those neurons was enough to recover the structural changes without restoring the head twitch.

In other words, the two effects could be separated by changing where a particular receptor was expressed in the brain.

This distinction is important, although the behavior does not directly establish whether mice experience hallucinations. 

Instead, it demonstrates that the cellular mechanism responsible for structural brain changes can operate independently of this particular psychedelic-associated response.

A possible route to psychedelic-inspired medicines

This distinction could have important implications for developing new psychiatric treatments.

The findings could help scientists develop psychiatric treatments that encourage neuroplasticity, the brain’s ability to adapt by forming new connections between nerve cells and reorganizing existing ones. 

This ability is particularly important because conditions such as depression and post-traumatic stress disorder (PTSD) can disrupt the brain circuits involved in mood and behavior. 

If researchers can develop compounds that stimulate this natural rebuilding process without triggering psychedelic effects, they could potentially harness some of psilocybin’s benefits without requiring patients to undergo an intense psychedelic experience.

“By showing that therapeutic circuit remodeling and hallucinogenic effects operate through distinct cellular pathways, our study provides a promising blueprint for designing non-hallucinogenic drug analogs,” Zuo said.

Such drugs could potentially make psychedelic-inspired treatments easier to administer, without the need for the same level of supervision required during psychedelic-assisted therapy.

But the leap from mice to medicine is a substantial one. The researchers measured structural changes in neural connections, not clinical improvements in mental health. They also have yet to demonstrate that a drug can reliably reproduce these changes in humans without causing psychedelic effects.

For now, the most significant finding isn’t that scientists have eliminated the psychedelic trip. It’s that they’ve identified a cellular mechanism that could one day allow them to do so while preserving some of psilocybin’s effects on the brain.

The study is published in the journal Nature Neuroscience.